Found 49 matching trials
Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1 PHASE2 This is a single-center, prospective, single-arm, open-label phase II study...
Location
Asan Medical Center
Learn More & Join Trial
Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression PHASE2 This trial will assess the 6-month complete response rate and toxicity prof...
Show More Location
Indiana University Melvin and Bren Simon Cancer Center
Learn More & Join Trial
TKI 258 in Von Hippel-Lindau Syndrome (VHL) PHASE2 The goal of this clinical research study is to learn if dovitinib can safel...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Dovitinib in Neuroendocrine Tumors PHASE2 This study is being conducted to evaluate whether the investigational drug ...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma PHASE1 In this study with a modified 3+3 dose finding design, a safe and tolerable...
Show More Location
Department of Neurology and Center of Integrated Oncology, University Hospital Bonn
Learn More & Join Trial
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer PHASE2 This is a prospective, multi-center, open-label, single-arm, non-randomized...
Show More Location
University of South Alabama / Mitchell Cancer Institute Univ South Alabama
Learn More & Join Trial
Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers PHASE1 This phase I trial is studying the side effects and best dose of dovitinib ...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC PHASE2 The main purpose of this study is to find out how useful dovitinib is when ...
Show More Location
Auckland Hospital
Learn More & Join Trial
Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma PHASE2 * Design: non-randomized, open label, phase II clinical trial.
* Study popu...
Show More Location
Complejo Hospitalario Universitario de Santiago
Learn More & Join Trial
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer PHASE2 This trial is designed to enroll postmenopausal patients with locally advan...
Show More Location
Ironwood Cancer and Research Centers SC
Learn More & Join Trial